Advancing human flourishing in New Hampshire and America by promoting ethical, emerging biotechnology in the Granite State.
Joined March 2026
- Tweets 82
- Following 89
- Followers 232
- Likes 290
13 Photos and videos
Granite Bio Innovation retweeted
At Power Hour this week:
Rep @mdrew4nh showed us we need to think about the State Budget NOW, not later.
Genesis Lung: “We weren’t meant to trash sick embryos, we were meant to fix them. Prenatal gene therapy is now a possibility.”
Support right to try ❤️
1
4
14
313
Granite Bio Innovation retweeted
Please join us this Friday, June 12, at 11:30am for NHLA Power Hour! At @AFP_NH in Manchester. Two guest speakers this week:
🏛️ Rep. Matt Drew @mdrew4nh presenting "State Budget Basics: Finding the Fat"
🧬 Genesis Lung presenting "A World Without Inherited Disease: Preventive Prenatal Care"
🗽RSVP for LUNCH!
1
8
17
1,397
A version of HB 1735 passed the NH Senate today. The version was heavily amended and, unfortunately, will not enable New Hampshire to become a commercial-scale hub for experimental therapies.
Granite Bio Innovation attempted to accept most of the Senate’s amendment while pursuing minimal changes that would allow a modest step in the right direction. Regrettably, these discussions did not produce a workable pathway for any of the firms and patients we support.
We will continue to support New Hampshire's patients and innovators in the following ways:
• Shaping other areas of state legislation in a way that facilitates frontier biotechnology in New Hampshire.
• Advocating for state and federal regulatory policy that allows New Hampshire's biotech ecosystem to flourish.
• Serving as a nexus for innovators and pro-biotech policymakers, including through an annual conference in August and by providing resources to healthcare providers.
Follow Granite Bio Innovation to stay in touch and learn more about how you can get involved.
We are grateful to the many New Hampshire officials who have championed the state's promise as a biotech hub, including Governor @KellyAyotte and @NHSpeaker for supporting the passage of Right to Try reforms as part of SB 504.
Across the US, momentum is growing for policy reforms that allow experimental therapies. These reforms will come from both federal agencies and state legislatures. It remains to be seen which states will lead the way.
The NH Senate has again rejected Right to Try, shutting the door on patients seeking experimental treatments. A few state senators have decided that New Hampshire is closed for business to biotech firms offering frontier therapies.
Here's what happened and our next steps.
This term, a bipartisan majority of the state House passed HB 1734 and HB 1735: two bills to make New Hampshire the best state in America for experimental therapies. The bills were based largely on existing laws in Montana and Florida.
Granite Bio Innovation—and the businesses and patients we support—helped build a coalition across every branch of elected state government to support these bills. We also worked for several months to build consensus in the Senate. Senators received calls from patients, businesses, investors, scientists, and healthcare providers supporting the bills.
After Senator David Rochefort requested a long list of changes to HB 1734, the biotech firms involved agreed to every change. But these negotiations were not in good faith. Senator Rochefort abruptly decided he would not accept any version of the bills, and the Senate rejected both.
The New Hampshire House then attached both bills to Senate Bill 504—this time with an even broader bipartisan vote of 197 to 145. Rather than negotiate a compromise, the Senate decided to fight this bill at any cost.
Sadly, there is no pathway for making New Hampshire a commercial-scale hub for experimental therapies until the composition of the NH Senate changes.
Until then, Granite Bio Innovation will continue to support New Hampshire's patients and innovators in the following ways:
• Shaping other areas of state legislation in a way that facilitates frontier biotechnology in New Hampshire.
• Advocating for state and federal regulatory policy that allows New Hampshire's biotech ecosystem to flourish.
• Serving as a nexus for innovators and pro-biotech policymakers, including through an annual conference in August and by providing resources to healthcare providers.
We are grateful to the many New Hampshire officials who have embraced the state's promise as a biotech hub, including @NHHouseGOP leadership, Governor @KellyAyotte, Mayor @JayRuais, and those senators who supported Right to Try on the Senate floor.
We are especially grateful to @NHSpeaker for sponsoring the amendment to SB 504 and to Representatives @KesselringSteve and @cole4nh for their tireless leadership on these bills and courageous stand for patients in need.
With a biotech revolution approaching, a US state will soon become a hub for experimental therapies. The only question now is which one.
3
5
41
5,989
Granite Bio Innovation retweeted
May 28
.@NHSpeaker on Senate rejecting last week expanded Right to Try Act. "The Senate declined to pursue this legislation, turning down billions of dollars of economic activity and shutting down the expansion of health and wellness pathways for every Granite Stater." #nhpolitics
10
19
64
12,238
Granite Bio Innovation retweeted
Sad to hear of former Rep. Michael Yakubovich’s passing.
He inspired us all with his bravery and advocacy for fellow patients battling rare diseases.
Joe and I are praying for Michael’s wife Marika, his family, and his friends and former colleagues.
7
15
103
5,766
Granite Bio Innovation retweeted
May 22
As a NH legislator and MS warrior of 25 years, I was in full support of this bill. Those of us with debilitating chronic illness deserve to be given the opportunity to live a fuller life. We know the risks and are willing to accept them to lessen our suffering.
The NH Senate has again rejected Right to Try, shutting the door on patients seeking experimental treatments. A few state senators have decided that New Hampshire is closed for business to biotech firms offering frontier therapies.
Here's what happened and our next steps.
This term, a bipartisan majority of the state House passed HB 1734 and HB 1735: two bills to make New Hampshire the best state in America for experimental therapies. The bills were based largely on existing laws in Montana and Florida.
Granite Bio Innovation—and the businesses and patients we support—helped build a coalition across every branch of elected state government to support these bills. We also worked for several months to build consensus in the Senate. Senators received calls from patients, businesses, investors, scientists, and healthcare providers supporting the bills.
After Senator David Rochefort requested a long list of changes to HB 1734, the biotech firms involved agreed to every change. But these negotiations were not in good faith. Senator Rochefort abruptly decided he would not accept any version of the bills, and the Senate rejected both.
The New Hampshire House then attached both bills to Senate Bill 504—this time with an even broader bipartisan vote of 197 to 145. Rather than negotiate a compromise, the Senate decided to fight this bill at any cost.
Sadly, there is no pathway for making New Hampshire a commercial-scale hub for experimental therapies until the composition of the NH Senate changes.
Until then, Granite Bio Innovation will continue to support New Hampshire's patients and innovators in the following ways:
• Shaping other areas of state legislation in a way that facilitates frontier biotechnology in New Hampshire.
• Advocating for state and federal regulatory policy that allows New Hampshire's biotech ecosystem to flourish.
• Serving as a nexus for innovators and pro-biotech policymakers, including through an annual conference in August and by providing resources to healthcare providers.
We are grateful to the many New Hampshire officials who have embraced the state's promise as a biotech hub, including @NHHouseGOP leadership, Governor @KellyAyotte, Mayor @JayRuais, and those senators who supported Right to Try on the Senate floor.
We are especially grateful to @NHSpeaker for sponsoring the amendment to SB 504 and to Representatives @KesselringSteve and @cole4nh for their tireless leadership on these bills and courageous stand for patients in need.
With a biotech revolution approaching, a US state will soon become a hub for experimental therapies. The only question now is which one.
2
3
11
512
Granite Bio Innovation retweeted
May 21
We moved the conversation forward after a year of work in the House to advance these bills for patients suffering from rare diseases and to push forward the future of medical innovation.
The Senate made the wrong decision today, choosing not to stand with patients and not to support the kind of breakthrough treatments that can save lives.
As a campaign promise in my run for Congress, I will always fight for patients’ ability to live and for families to have real hope through access to breakthrough treatments, experimental options, and medical innovation that can change lives. I will not accept a system that leaves people waiting when time is not on their side.
Every person deserves the chance to save their own life, and I will take that fight to Washington.
8
24
541
The NH Senate has again rejected Right to Try, shutting the door on patients seeking experimental treatments. A few state senators have decided that New Hampshire is closed for business to biotech firms offering frontier therapies.
Here's what happened and our next steps.
This term, a bipartisan majority of the state House passed HB 1734 and HB 1735: two bills to make New Hampshire the best state in America for experimental therapies. The bills were based largely on existing laws in Montana and Florida.
Granite Bio Innovation—and the businesses and patients we support—helped build a coalition across every branch of elected state government to support these bills. We also worked for several months to build consensus in the Senate. Senators received calls from patients, businesses, investors, scientists, and healthcare providers supporting the bills.
After Senator David Rochefort requested a long list of changes to HB 1734, the biotech firms involved agreed to every change. But these negotiations were not in good faith. Senator Rochefort abruptly decided he would not accept any version of the bills, and the Senate rejected both.
The New Hampshire House then attached both bills to Senate Bill 504—this time with an even broader bipartisan vote of 197 to 145. Rather than negotiate a compromise, the Senate decided to fight this bill at any cost.
Sadly, there is no pathway for making New Hampshire a commercial-scale hub for experimental therapies until the composition of the NH Senate changes.
Until then, Granite Bio Innovation will continue to support New Hampshire's patients and innovators in the following ways:
• Shaping other areas of state legislation in a way that facilitates frontier biotechnology in New Hampshire.
• Advocating for state and federal regulatory policy that allows New Hampshire's biotech ecosystem to flourish.
• Serving as a nexus for innovators and pro-biotech policymakers, including through an annual conference in August and by providing resources to healthcare providers.
We are grateful to the many New Hampshire officials who have embraced the state's promise as a biotech hub, including @NHHouseGOP leadership, Governor @KellyAyotte, Mayor @JayRuais, and those senators who supported Right to Try on the Senate floor.
We are especially grateful to @NHSpeaker for sponsoring the amendment to SB 504 and to Representatives @KesselringSteve and @cole4nh for their tireless leadership on these bills and courageous stand for patients in need.
With a biotech revolution approaching, a US state will soon become a hub for experimental therapies. The only question now is which one.
20
25
104
17,536
We're proud to announce that innovator and patient advocate Yiwei She has joined our board of scientific advisors.
Yiwei is the Founder and CEO of the TNPO2 Foundation, a nonprofit dedicated to advancing genomic medicine and improving outcomes for children with ultra-rare neurodevelopmental disorders. Driven by her personal experience navigating her son Leo's diagnosis, Yiwei has transformed her family's journey into a mission to ensure no family faces these challenges alone.
She initiated Project Baby Lion, a groundbreaking clinical trial for New York State, providing rapid Whole Genome Sequencing (rWGS) for critically ill newborns in the NICU at Stony Brook Children's Hospital. This study bridges translational research and clinical practice to accelerate the path from genomic discovery to bedside diagnosis.
Yiwei is personally committed to dismantling the systemic barriers that keep life-saving genomic precision medicine out of reach for families.
2
16
838
Granite Bio Innovation retweeted
May 20
.@cole4nh on @KellyAyotte backing expanded Right to Try/experimental treatment center bills. “These bills will not only expand treatment options for patients and families facing serious illnesses, but also position NH to become the brain trust of American biotech innovation."
4
17
1,027
Thank you, @KellyAyotte, for standing for patients.
New Hampshire is ideally positioned to become the best state in the US for frontier biotech.
When SB 504 passes, we are ready to work hard to make emerging therapies a key part of the New Hampshire advantage.
May 20
Gov. @KellyAyotte tells reporters she is supportive of bills moving forward in the legislature to expand right-to-try & expanded experimental access in New Hampshire. Supporters contend these bills could provide a biotech economic boost for the state. #NHPolitics #WMUR
9
45
3,680
Granite Bio Innovation retweeted
May 20
This is really going to be huge for New Hampshire. Let's get this done!
Thank you, Governor @KellyAyotte!
May 20
Gov. @KellyAyotte tells reporters she is supportive of bills moving forward in the legislature to expand right-to-try & expanded experimental access in New Hampshire. Supporters contend these bills could provide a biotech economic boost for the state. #NHPolitics #WMUR
5
18
137
6,471
Granite Bio Innovation retweeted
The Alliance for Longevity Initiatives (A4LI) would like to provide an update regarding New Hampshire’s ongoing efforts to expand patient access to investigational medical treatments and strengthen the state’s position as a hub for biomedical innovation.
This week, legislative language from HB1734 and HB1735 was successfully attached to SB504 through the amendment process in the New Hampshire House of Representatives, keeping these reforms active as negotiations continue.
HB1734 would authorize the establishment of experimental treatment centers capable of offering eligible investigational therapies under state oversight, while HB1735 would expand New Hampshire’s Right to Try framework to include patients suffering from chronic and debilitating conditions
We would especially like to thank House Speaker Sherman Packard (@NHSpeaker) and Majority Leader Jason Osborne (@Osborne4NH) for their leadership and continued support. Together, these proposals continue New Hampshire’s emergence as one of the most forward-looking states in the country on medical innovation, patient autonomy, and access to next-generation therapies.
As the process continues, we encourage everyone to respectfully reach out to Senate President Sharon Carson, Senator Rochefort, and Senator Birdsell and urge them to support SB504 as amended during committee of conference negotiations.
We look forward to continuing to work with lawmakers, patients, advocates, and innovators as this effort progresses.
2
5
22
504
Granite Bio Innovation retweeted
May 14
KESSELRING: NH Should Give Rare-Disease Patients the ‘Right To Try’
nhjournal.com/kesselring-nh-…
@nhgop @nhdems
3
7
21
595
The New Hampshire House has again voted in favor of HB 1734 and HB 1735 - two bills to make New Hampshire a hub for experimental therapies.
SB 504 was amended to include both bills and then passed the House 197-145, this time picking up several Democrats.
5
15
101
47,755
A New Hampshire Senate committee has voted to block patients from accessing experimental treatments. Now is the time to call your state senator and stand for patients.
New Hampshire patients deserve the right to try cutting-edge therapies without waiting on Washington. Two bills now before the NH Senate, HB 1734 and HB 1735, would create a solid pathway for emerging treatments here in NH.
Both bills cleared the NH House with the support of every House Republican and some Democrats. But on May 6, the Senate HHS Committee voted to send the bills to "Interim Study" — a way of killing the bills. The full Senate will hear the bills on Thursday, May 14.
Follow the link below to call your state senator now. Tell your senator to vote NO on Interim Study and YES on HB 1734 and HB 1735.
2
4
22
958
Granite Bio Innovation retweeted
May 6
FDA is too slow.
HB1734 provides a framework for experimental clinics to deliver results AND data sooner!
This should be an obvious one for the "Live Free or Die" state.
LFG. Come on now!
New Hampshire’s Right to Try bills, HB 1734 and HB 1735, faced a setback today when the Senate HHS Committee voted against both bills. These bills will make NH the best state in America for emerging therapies—drawing on successful laws already passed in Montana and other states.
While both Senate Democrats opposed the bills, Republicans on the committee were divided—with GOP Senators Regina Birdsell and Dan Innis both indicating they were prepared to support the bills.
We remain optimistic. These bills earned the votes of every single Republican and some Democrats in the New Hampshire House. Elected leaders know that these bills will help patients and expand the New Hampshire Advantage.
We believe both bills will pass this month—we’ll just have to take the long way to get there. Learn more and take action below.
1
5
113
Granite Bio Innovation retweeted
May 6
Every day I speak with patients in desperate need of treatment.
Bills like HB 1734 and 1735 are needed to make it possible for me to recommend them to New Hampshire.
Without these special facilities its impossible to find the doctors needed in NH to actually administer treatment.
Just recently I experienced this while trying, and failing, to organize treatment under HB701.
Please check out the action items in the tweet thread below, the fight isn't over yet.
@LPNH @jeremykauffman @FreeStateNH
New Hampshire’s Right to Try bills, HB 1734 and HB 1735, faced a setback today when the Senate HHS Committee voted against both bills. These bills will make NH the best state in America for emerging therapies—drawing on successful laws already passed in Montana and other states.
While both Senate Democrats opposed the bills, Republicans on the committee were divided—with GOP Senators Regina Birdsell and Dan Innis both indicating they were prepared to support the bills.
We remain optimistic. These bills earned the votes of every single Republican and some Democrats in the New Hampshire House. Elected leaders know that these bills will help patients and expand the New Hampshire Advantage.
We believe both bills will pass this month—we’ll just have to take the long way to get there. Learn more and take action below.
3
14
1,202